ANGPTL4 and cancer: Given that the regulation of the SASP has attracted much interest over the last decade to improve various age‐related diseases, including cancer (Zhang et al. 2023; Soto‐Gamez and Demaria 2017), our work paves the way for the development of preventive and therapeutic strategies blocking the deleterious effects of the proinflammatory SASP by targeting ANGPTL4 or its upstream regulators.